CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - shares		12 Months Ended
Nov. 24, 2020	Jun. 30, 2021
Over-allotment option
Sale of Units, net of underwriting discounts and offering expenses (in shares)	509,041
Private Placement \| Private Placement Warrants
Sale of Units, net of underwriting discounts and offering expenses (in shares)		8,009,041
Sale of Private Placement Warrants (in shares)	3,146,454	3,146,454

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant